While remimazolam does not seems to affect RyR1 directly, the IP3-dependent calcium elevation mediated by remimazolam could play a role in sensitizing RyR1 in an individual with Malignant Hyperthermia (MH) susceptibility. This evidence concerns the gene RYR1 and Malignant hyperthermia.